Cargando…
Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
BACKGROUND: “FFM ME-TRAP” is sequential immunisation with two attenuated poxvirus vectors (FP9 and modified vaccinia virus Ankara) delivering the pre-erythrocytic malaria antigen ME-TRAP. Over nine months follow-up in our original study, there was no evidence that FFM ME-TRAP provided protection aga...
Autores principales: | Bejon, Philip, Ogada, Edna, Mwangi, Tabitha, Milligan, Paul, Lang, Trudie, Fegan, Greg, Gilbert, Sarah C., Peshu, Norbert, Marsh, Kevin, Hill, Adrian V.S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940326/ https://www.ncbi.nlm.nih.gov/pubmed/17710125 http://dx.doi.org/10.1371/journal.pone.0000707 |
Ejemplares similares
-
A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
por: Bejon, Philip, et al.
Publicado: (2006) -
Immunogenicity of ChAd63 + MVA ME-TRAP in Senegalese adults
por: Mensah, Victorine, et al.
Publicado: (2014) -
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
por: Afolabi, Muhammed O, et al.
Publicado: (2016) -
Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children
por: Bowyer, Georgina, et al.
Publicado: (2014) -
Correction: Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children
por: Bejon, Philip, et al.
Publicado: (2011)